1) Ashbaugh DG, et al:Acute respiratory distress in adults. Lancet ⅱ:319-323, 1967
2) Petty TL, Ashbaugh DG:The adult respiratory distress syndrome;Clinical features, factors influencing prognosis and principles of management. Chest 60:233-239, 1971
3) Ware LB, Matthay MA:The acute respiratory distress syndrome. N Engl J Med 342:1334-1349, 2000
4) Bernard GR, et al:The American-European Consensus Conference on ARDS;Definitions, mechanisms, relevant outcomes, and clinical coordination. Am J Respir Crit Care Med 149:818-824, 1994
5) Rubenfeld GD, et al:Incidence and outcomes of acute lung injury. N Engl J Med 353:1685, 2005
6) Bone RC, et al:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis;The ACCP/SCCM Consensus Conference Committee. Chest 101:1644-1655, 1992
7) 小川道雄:侵襲と好中球エラスターゼ.Prog Med 22:1019-1035, 2002
8) Hudson LD, Steinberg KP:Epidemiology of acute lung injury and ARDS. Chest 116:74S-82S, 1999
9) The Acute Respiratory Distress Syndrome Network:Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301-1308, 2000
10) Bernard GR, et al:Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001
11) Tamakuma S, et al:Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 17:271-279, 2004
12) Pinhu L, et al:Ventilator-associated lung injury. Lancet 361:332-340, 2003
13) The ARDS Clinical Trials Network:Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671-1684, 2006
14) 日本呼吸器学会ARDSガイドライン作成委員会(編):ALI/ARDS診療のためのガイドライン,日本呼吸器学会,2005